Evidence map›Paper›PMID 39416975›Full record

ArticleTherapeutic advances in ophthalmology

Neurochemistry and functional connectivity in the brain of people with Charles Bonnet syndrome.

Holly Bridge, Abigail Wyllie, Aaron Kay, Bailey Rand, Lucy Starling, Rebecca S Millington-Truby, William T Clarke, Jasleen K Jolly, I Betina Ip

Abstract read
In one paragraph

Article in Therapeutic advances in ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Charles Bonnet syndrome in patients referred for cataract surgery.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Charles Bonnet Syndrome associated with unilateral vision loss: A new diagnostic perspective.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Holly BridgeWellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neurosciences, Oxford, UK.ORCID https://orcid.org/0000-0002-8089-6198
Abigail WyllieWellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neurosciences, Oxford, UK.ORCID https://orcid.org/0009-0005-7886-4292
Aaron KayWellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neurosciences, Oxford, UK.
Bailey RandWellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neurosciences, Oxford, UK.
Lucy StarlingWellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neurosciences, Oxford, UK.ORCID https://orcid.org/0000-0002-0347-8259
Rebecca S Millington-TrubyWellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neurosciences, Oxford, UK.ORCID https://orcid.org/0000-0002-3554-4273
William T ClarkeWellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neurosciences, Oxford, UK.ORCID https://orcid.org/0000-0001-7159-7025
Jasleen K JollyWellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neurosciences, Oxford, UK.ORCID https://orcid.org/0000-0001-9878-4621
I Betina IpWellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neurosciences, Headley Way, Oxford OX3 9DU, UK.ORCID https://orcid.org/0000-0003-3544-0711

Funding

Medical Research Council MR/V034723/1Wellcome Trust
6 · The paper itself

Abstract

Background: Charles Bonnet syndrome (CBS) is a condition in which people with vision loss experience complex visual hallucinations. These complex visual hallucinations may be caused by increased excitability in the visual cortex that are present in some people with vision loss but not others. Objectives: We aimed to evaluate the association between γ-aminobutyric acid (GABA) in the visual cortex and CBS. We also tested the relationship among visually evoked responses, functional connectivity, and CBS. Design: This is a prospective, case-controlled, cross-sectional observational study. Methods: We applied 3-Tesla magnetic resonance spectroscopy, as well as task-based and resting state (RS) connectivity functional magnetic resonance imaging in six participants with CBS and six controls without CBS. GABA+ was measured in the early visual cortex (EVC) and in the lateral occipital cortex (LOC). Participants also completed visual acuity and cognitive tests, and the North-East Visual Hallucinations Interview. Results: The two groups were well-matched for age, gender, visual acuity and cognitive scores. There was no difference in GABA+ levels between groups in the visual cortex. Most participants showed the expected blood oxygenation level dependent (BOLD) activation to images of objects and the phase-scrambled control. Using a fixed effects analysis, we found that BOLD activation was greater in participants with CBS compared to controls. Analysis of RS connectivity with LOC and EVC showed little difference between groups. A fixed effects analysis showed a correlation between the extent of functional connectivity with LOC and hallucination strength. Conclusion: Overall, our results provide no strong evidence for an association between GABAergic inhibition in the visual cortex and CBS. We only found subtle differences in visual function and connectivity between groups. These findings suggest that the neurochemistry and visual connectivity for people with Charles Bonnet hallucinations are comparable to a sight loss population. Differences between groups may emerge when investigating subtle and transient changes that occur at the time of visual hallucinations.

Indexed as

Charles Bonnet syndromefMRIGABAresting state connectivityvisual hallucination

Identifiers

PMID39416975
PMCPMC11481065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.